Thema
Journal Article
192
Research Support, Non-U.S. Gov't
148
Review
55
Cancer Vaccines
31
615
26
che
26
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
25
Immunotherapy
20
Programmed Cell Death 1 Receptor
19
Antigens, Neoplasm
15
C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000)
15
Cytokines
15
Antineoplastic Agents
14
Biomarkers, Tumor
13
B7-H1 Antigen
12
PDCD1 protein, human
12
82115-62-6
11
Biomarker
11
Interferon-gamma
11
immunotherapy
11
HPV
10
Multicenter Study
10
Angiogenesis Inhibitors
9
Antibodies, Monoclonal
9
CD274 protein, human
9
Neoplasm Proteins
9
PD-L1
9
Antibodies, Viral
8
Biomarkers
8
Cancer vaccine
8
Letter
8
Resident memory T cells
8
Sunitinib
8
V99T50803M
8
A61N: Electrotherapy; magnetotherapy; radiation therapy; ultrasound therapy (measurement of bioelectric currents a61b;surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body a61b0018000000;anaesthetic apparatus in general a61m;incandescent lamps h01k;infra-red radiators for heating h05b)
7
Adjuvants, Immunologic
7
Antigens
7
Antineoplastic Agents, Immunological
7
Bevacizumab
7
Epitopes, T-Lymphocyte
7
FDA, Food and Drug Administration
7
Regulatory T cells
7
Shiga Toxins
7
TLR, Toll-like receptor
7
cancer vaccine
7
Medium
7
9006-59-1
6
CTLA-4 Antigen
6
Cancer
6
EC 2.7.10.1
6
mehr ...